Cue Biopharma, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $54.6M | $44.3M |
| FY2020 | — | $78.9M | $74.9M |
| FY2021 | $0 | $65.5M | $64.4M |
| FY2022 | $8.0M | $65.7M | $51.6M |
| FY2023 | $4.2M | $37.1M | $48.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $54.6M | $44.3M |
| FY2020 | — | $78.9M | $74.9M |
| FY2021 | $0 | $65.5M | $64.4M |
| FY2022 | $8.0M | $65.7M | $51.6M |
| FY2023 | $4.2M | $37.1M | $48.5M |